This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
07/30/15 - 3:59:12 PM ET (BATS BZX Real-time Price)
Div Yield: --
GHDX Day's Range
GHDX 52 Week Range
GHDX Business Summary
Genomic Health, Inc., a healthcare company, provides actionable genomic information to personalize cancer treatment decisions in the United States and internationally.View GHDX key stats
Genomic Health Inc - GHDX - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Genomic Health Inc as a
Sell with a ratings score of D.
Report Snippet: We rate GENOMIC HEALTH INC (GHDX) a SELL. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.